By submitting you agree to the Terms of Service. Prestige CBD $ 25.00. We also use third-party cookies that help us analyze and understand how you use this website. home; Press; CannaKids & CURE Pharmaceutical Announce Research Collaboration with Technion Institute in Israel June 26, 2017 - Blog. Suggested Locations. Tracy Ryan is the CEO and lead consultant for CannaKids, a California-based cooperative with a focus on supplying medical cannabis oil to adults and children looking for holistic relief for serious health conditions, specializing in pediatric cancer. Copyright © 2020 Green Rush Group. Researchers from CURE’s Pharmaceutical Cannabinoid Division and Technion’s Laboratory of Cancer Biology and Cannabinoid Research will work together to research and identify how varying cannabinoid compounds within cannabis strains can affect various cancer subtypes. In addition to the research in Israel, CannaKids is in the planning phase with a major hospital in California and is expected to start in-hospital clinical trials on pediatric patients in the next year. +19165380593 Sales@prerollcigarsandvapes.com
CannaKids is on a trajectory to being one of the world’s leaders for cannabinoid therapy based on scientific research, and is in collaboration with some of the top researchers, doctors, and hospitals in the world. CannaKids - Spectrum THCa Tincture 750mg. We are a California-based brand with a focus on supplying medical cannabis oil tinctures and cannabis products to patients of all ages. We are in a brave new world of plant-based cannabinoid medicines, and it is an honor to be working alongside such brilliant minds.” Shop. CannaKids has been sharing their meticulously tracked patient data with Technion in order to help further assist in their research. You will receive periodic emails from Ryland Pharms and can update your email preferences at any time. We use our own and third-party cookies to improve your experience and our services, and analyze the use of our website.
With a true passion for clinical research Tracy has partnered with, and is on the Advisory Board of, CURE Pharmaceutical, (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, and the Technion Institute in Israel who is leading the way in cannabis research for cancer.